Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease-Reference-Cited by-同舟云学术

Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease

Published:2008-04-28 Issue:5 Volume:40 Page:529-537
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Monti Jan,Fischer Judith,Paskas Svetlana,Heinig Matthias,Schulz Herbert,Gösele Claudia,Heuser Arnd,Fischer Robert,Schmidt Cosima,Schirdewan Alexander,Gross Volkmar,Hummel Oliver,Maatz Henrike,Patone Giannino,Saar Kathrin,Vingron Martin,Weldon Steven M,Lindpaintner Klaus,Hammock Bruce D,Rohde Klaus,Dietz Rainer,Cook Stuart A,Schunck Wolf-Hagen,Luft Friedrich C,Hubner Norbert

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng.129.pdf

Reference49 articles.

1. Kannel, W.B. & Belanger, A.J. The epidemiology of heart failure. Am. Heart J. 121, 951–957 (1991).

2. Levy, D. et al. Long-term trends in the incidence of and survival with heart failure. N. Engl. J. Med. 347, 1397–1402 (2002).

3. Owan, T.E. et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N. Engl. J. Med. 355, 251–259 (2006).

4. Chien, K.R. Genomic circuits and the integrative biology of cardiac diseases. Nature 407, 227–232 (2000).

5. Kostis, J.B. et al. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. J. Am. Med. Assoc. 278, 212–216 (1997).

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CYP2J2-mediated metabolism of arachidonic acid in heart: A review of its kinetics, inhibition and role in heart rhythm control;Pharmacology & Therapeutics;2024-06

2. The involvement of soluble epoxide hydrolase in the development of cardiovascular diseases through epoxyeicosatrienoic acids;Frontiers in Pharmacology;2024-04-02

3. Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against heart failure via increasing epoxyeicosatrienoic acids;Journal of Molecular and Cellular Cardiology;2023-12

4. Investigating the relevance of CYP2J2 inhibition for drugs known to cause intermediate to high risk torsades de pointes;European Journal of Pharmaceutical Sciences;2023-08

5. Transcriptome data analysis of primary cardiomyopathies reveals perturbations in arachidonic acid metabolism;Frontiers in Cardiovascular Medicine;2023-05-23